Want to see IT:EUK full AI Analyst Report?
EUK Stock Chart & Stats
€0.72
-€0.02(-2.41%)
At close: 4:00 PM EST
€0.72
-€0.02(-2.41%)
Day’s Range― - ―
52-Week Range€0.45 - €0.81
Previous CloseN/A
Volume1.70K
Average Volume (3M)433.00
Market Cap
€12.85M
Enterprise Value€10.00T>
Total Cash (Recent Filing)€848.00K
Total Debt (Recent Filing)€128.99M
Price to Earnings (P/E)28.1
Beta0.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.3%
Share Statistics
EPS (TTM)N/A
Shares Outstanding22,741,629
10 Day Avg. Volume460
30 Day Avg. Volume433
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)0.55
Price to Sales (P/S)0.31
P/FCF Ratio36.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Positive Operating Cash FlowConsistently positive operating cash flow provides an internal funding base for care operations and helps service obligations despite weak reported earnings. This recurring cash generation is a durable support, although it does not fully offset volatile cash available after investment and working-capital needs.
Resilient Operating MarginsEBIT margins of roughly 9–11% and EBITDA margins of 20–25% across 2021–2025 indicate that core operations retained profitability despite flat revenue and recent net losses. This resilience can support service continuity and recovery if earnings improve.
Care Services FocusEukedos operates in healthcare and social care, providing residential and semi-residential services to dependent and non-self-sufficient individuals. Its facility-based operating model is directly tied to ongoing care provision, supporting business continuity beyond short-term market conditions.
Bears Say
Very High LeverageVery high leverage and the 2025 increase in total debt reduce balance-sheet flexibility and heighten sensitivity to refinancing costs and interest rates. The relatively small equity base leaves less capacity to absorb operating setbacks or fund future investment internally.
Recent Net LossesFlat revenue limits the growth base, while the return to net losses in 2024 and 2025 weakens earnings quality after modest profits in 2021–2023. Without renewed bottom-line profitability, internal capital formation and financial resilience remain constrained.
Volatile Free Cash FlowVolatile free cash flow means positive operating cash generation has not translated consistently into cash remaining after capital expenditure and working-capital needs. This uneven conversion can limit debt reduction, investment capacity, and the ability to withstand weaker results.
Eukedos S.p.A. News
EUK FAQ
What was Eukedos S.p.A.’s price range in the past 12 months?
Eukedos S.p.A. lowest stock price was €0.45 and its highest was €0.81 in the past 12 months.
What is Eukedos S.p.A.’s market cap?
Eukedos S.p.A.’s market cap is €12.85M.
When is Eukedos S.p.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eukedos S.p.A.’s earnings last quarter?
Currently, no data Available
Is Eukedos S.p.A. overvalued?
According to Wall Street analysts Eukedos S.p.A.’s price is currently Overvalued.
Does Eukedos S.p.A. pay dividends?
Eukedos S.p.A. pays a Notavailable dividend of €0.044 which represents an annual dividend yield of 5.3%. See more information on Eukedos S.p.A. dividends here
What is Eukedos S.p.A.’s EPS estimate?
Eukedos S.p.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eukedos S.p.A. have?
Eukedos S.p.A. has 22,741,629 shares outstanding.
What happened to Eukedos S.p.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eukedos S.p.A.?
Currently, no hedge funds are holding shares in IT:EUK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eukedos S.p.A.
EuKedos S.p.A. operates in Italy, offering a range of managed and long-term care provisions. The company specializes in delivering residential social support for older adults, catering to both independent individuals and those needing extensive assistance. With 1,345 beds, it oversees healthcare and residential care facilities throughout northern and central Italy, notably in regions such as Lombardy, Piedmont, Abruzzo, Valle D'Aosta, and Emilia Romagna. EuKedos S.p.A. is headquartered in Florence, Italy.
Technical Analysis
Arterra Bioscience SpA
―
Farmacosmo S.P.A.
―
Svas Biosana S.p.A.
―
I.M.D. International Medical Devices S.P.A.
―
Piu Medical S.P.A.
―